loading
Precedente Chiudi:
$3.27
Aprire:
$3.25
Volume 24 ore:
3.00M
Relative Volume:
0.94
Capitalizzazione di mercato:
$879.76M
Reddito:
$8.10M
Utile/perdita netta:
$-92.72M
Rapporto P/E:
-9.4706
EPS:
-0.34
Flusso di cassa netto:
$-82.52M
1 W Prestazione:
+2.38%
1M Prestazione:
+10.45%
6M Prestazione:
+154.94%
1 anno Prestazione:
+59.65%
Intervallo 1D:
Value
$3.22
$3.355
Intervallo di 1 settimana:
Value
$3.04
$3.355
Portata 52W:
Value
$1.05
$3.40

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name
Nome
Taysha Gene Therapies Inc
Name
Telefono
(214) 612-0000
Name
Indirizzo
3000 PEGASUS PARK DRIVE, DALLAS
Name
Dipendente
73
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
TSHA's Discussions on Twitter

Confronta TSHA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TSHA
Taysha Gene Therapies Inc
3.225 892.04M 8.10M -92.72M -82.52M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
404.37 100.41B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
609.00 59.59B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
459.88 59.77B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
770.12 45.14B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
342.98 37.42B 3.81B -644.79M -669.77M -6.24

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-11 Iniziato BofA Securities Buy
2024-06-27 Iniziato BMO Capital Markets Outperform
2024-04-09 Iniziato Piper Sandler Overweight
2023-02-01 Downgrade Jefferies Buy → Hold
2023-01-27 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-11-09 Downgrade Goldman Buy → Neutral
2022-03-09 Iniziato Robert W. Baird Outperform
2022-03-01 Iniziato Wells Fargo Overweight
2022-02-18 Iniziato SMBC Nikko Outperform
2021-12-16 Iniziato Guggenheim Buy
2021-07-16 Iniziato Needham Buy
2021-06-24 Iniziato Truist Buy
2021-06-15 Iniziato BTIG Research Buy
2021-06-09 Iniziato Wedbush Outperform
2021-06-08 Iniziato JMP Securities Mkt Outperform
2021-05-19 Iniziato Cantor Fitzgerald Overweight
2021-05-11 Ripresa Jefferies Buy
2021-02-24 Iniziato William Blair Outperform
2021-01-05 Iniziato Oppenheimer Outperform
2020-10-19 Iniziato Chardan Capital Markets Buy
2020-10-19 Iniziato Goldman Buy
2020-10-19 Iniziato Jefferies Buy
2020-10-19 Iniziato Morgan Stanley Overweight
Mostra tutto

Taysha Gene Therapies Inc Borsa (TSHA) Ultime notizie

pulisher
06:34 AM

Will Taysha Gene Therapies Inc. stock continue dividend increasesPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com

06:34 AM
pulisher
05:25 AM

How to interpret RSI for Taysha Gene Therapies Inc. stockMarket Activity Report & Consistent Profit Trading Strategies - newser.com

05:25 AM
pulisher
04:35 AM

Will Taysha Gene Therapies Inc. stock maintain growth storyWall Street Watch & Risk Managed Investment Signals - newser.com

04:35 AM
pulisher
Sep 30, 2025

Analyzing drawdowns of Taysha Gene Therapies Inc. with statistical toolsEarnings Growth Summary & Stepwise Swing Trade Plans - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Trading Down 4.5%Time to Sell? - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Is Taysha Gene Therapies Inc. trending in predictive chart modelsWeekly Trade Summary & Weekly Stock Performance Updates - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Taysha Gene Therapies Inc stockDouble Top/Bottom Patterns & Turn Data into Profits With Our Strategies - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Should You Track Rapid Investments Limited as a LongTerm Growth PlayWeekly Market Snapshot & Grow Smarter With Pro-Level Research - Early Times

Sep 28, 2025
pulisher
Sep 28, 2025

What drives Taysha Gene Therapies Inc stock priceCapital Gains Strategies & Rapid Profit Portfolio - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Sep 27, 2025
pulisher
Sep 26, 2025

Taysha Gene Therapies, Inc. $TSHA Shares Sold by Goldman Sachs Group Inc. - MarketBeat

Sep 26, 2025
pulisher
Sep 24, 2025

Taysha Gene Therapies, Inc. Experiences Revision in Stock Evaluation Amid Strong Performance - Markets Mojo

Sep 24, 2025
pulisher
Sep 24, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 8%Time to Buy? - MarketBeat

Sep 24, 2025
pulisher
Sep 22, 2025

Cantor Fitzgerald reiterates Overweight rating on Taysha Gene Therapies stock - Investing.com

Sep 22, 2025
pulisher
Sep 19, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Down 4.4% on Insider Selling - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Combining price and volume data for Taysha Gene Therapies Inc.M&A Rumor & Long-Term Safe Investment Ideas - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Sentiment analysis tools applied to Taysha Gene Therapies Inc.Earnings Growth Summary & Expert Curated Trade Setup Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Bank Watch: Can TNONW maintain its current growth rateWeekly Trade Recap & Technical Pattern Based Signals - khodrobank.com

Sep 19, 2025
pulisher
Sep 18, 2025

Is this a good reentry point in Taysha Gene Therapies Inc.2025 Market Trends & Long Hold Capital Preservation Plans - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Breakout Watch: What is the next catalyst for Taysha Gene Therapies IncJuly 2025 Movers & Daily Volume Surge Trade Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Is Taysha Gene Therapies Inc. building a consolidation baseShort Setup & Capital Efficient Trade Techniques - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Live market analysis of Taysha Gene Therapies Inc.2025 Top Gainers & Smart Allocation Stock Tips - newser.com

Sep 18, 2025
pulisher
Sep 17, 2025

Taysha Gene Therapies, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Sep 17, 2025
pulisher
Sep 17, 2025

Insider Selling: Taysha Gene Therapies (NASDAQ:TSHA) Insider Sells 200,000 Shares of Stock - MarketBeat

Sep 17, 2025
pulisher
Sep 16, 2025

Siren L.L.C. Has $9.06 Million Stock Holdings in Taysha Gene Therapies, Inc. $TSHA - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Downgrade Watch: How liquid is Taysha Gene Therapies Inc stockQuarterly Market Summary & Reliable Price Breakout Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Published on: 2025-09-16 23:25:17 - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Tech Rally: Will Taysha Gene Therapies Inc benefit from AI trendsProfit Target & Consistent Growth Equity Picks - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Returns Recap: How correlated is Taysha Gene Therapies Inc to the S P5002025 Top Gainers & Precise Entry and Exit Recommendations - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Risk Hedge: Is QUAD stock a falling knife or bargain buyJuly 2025 Sector Moves & Real-Time Market Trend Scan - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Insider Buy: Is Taysha Gene Therapies Inc attractive for institutional investors2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Quarterly Recap: Is Taysha Gene Therapies Inc. subject to activist investor interestOptions Play & Community Consensus Trade Signals - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Mood: What is the next catalyst for Taysha Gene Therapies IncJuly 2025 Update & Daily Growth Stock Tips - khodrobank.com

Sep 15, 2025
pulisher
Sep 15, 2025

Quarterly Recap: How liquid is Taysha Gene Therapies Inc. stockQuarterly Market Summary & AI Driven Stock Reports - خودرو بانک

Sep 15, 2025
pulisher
Sep 14, 2025

How to read the order book for Taysha Gene Therapies Inc.Market Risk Report & Verified Technical Trade Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Taysha Gene Therapies, Inc. $TSHA Shares Purchased by Octagon Capital Advisors LP - MarketBeat

Sep 14, 2025
pulisher
Sep 08, 2025

Screener Results Flag Taysha Gene Therapies Inc. as OversoldTrade Risk Summary & Verified Entry Point Signals - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Nuveen LLC Acquires New Holdings in Taysha Gene Therapies, Inc. $TSHA - MarketBeat

Sep 08, 2025
pulisher
Sep 07, 2025

ADAR1 Capital Management LLC Purchases 888,602 Shares of Taysha Gene Therapies, Inc. $TSHA - MarketBeat

Sep 07, 2025
pulisher
Sep 06, 2025

Published on: 2025-09-06 13:01:15 - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Real time breakdown of Taysha Gene Therapies Inc. stock performance2025 Analyst Calls & Momentum Based Trading Signals - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Volume Report: Is Taysha Gene Therapies Inc. benefiting from interest rate changesJuly 2025 Highlights & Low Risk High Reward Ideas - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

Taysha Gene Therapies Inc. stock prediction for this weekJobs Report & Verified Short-Term Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Aug Highlights: Can Taysha Gene Therapies Inc. outperform under higher oil pricesEarnings Growth Report & Fast Moving Stock Watchlists - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Published on: 2025-09-05 16:05:08 - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What institutional flow reveals about Taysha Gene Therapies Inc.2025 Winners & Losers & Daily Profit Focused Screening - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Taysha Gene Therapies Inc. stock entering bullish territoryQuarterly Market Review & Comprehensive Market Scan Reports - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Trapped Investors in Taysha Gene Therapies Inc. Await Breakout SignalJuly 2025 Momentum & Consistent Growth Equity Picks - beatles.ru

Sep 05, 2025
pulisher
Sep 05, 2025

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule 5635(c)(4) - MarketScreener

Sep 05, 2025
pulisher
Sep 05, 2025

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks

Sep 05, 2025
pulisher
Sep 05, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Li - GuruFocus

Sep 05, 2025

Taysha Gene Therapies Inc Azioni (TSHA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$35.80
price up icon 1.62%
$85.78
price up icon 1.20%
$31.39
price up icon 2.31%
$102.62
price up icon 4.05%
$144.32
price up icon 0.43%
biotechnology ONC
$343.34
price up icon 0.53%
Capitalizzazione:     |  Volume (24 ore):